The International Keratoconus Academy (IKA) advances its mission through eight strategic pillars that define the Academy’s priorities and guide its educational, scientific, clinical, and global initiatives. Together, these pillars reflect IKA’s commitment to advancing the science and clinical management of keratoconus and other corneal ectatic disorders while improving patient outcomes worldwide.
01
Education and Professional Development
Provide world-class educational programs that translate emerging scientific evidence into practical, evidence-based clinical care through scientific meetings, continuing education programs, webinars, publications, digital learning resources, and interdisciplinary collaboration. The Academy is committed to lifelong learning and the continuous advancement of clinical excellence among eye care professionals.
02
Research and Scientific Discovery
Promote and support basic science, translational, and clinical research that advances the understanding of keratoconus and other corneal ectatic disorders. IKA encourages multidisciplinary collaboration and scientific investigation that improves disease detection, enhances treatment strategies, and ultimately advances patient care.
03
Early Detection and Prevention
Champion the earliest possible diagnosis of keratoconus through advanced diagnostic technologies, comprehensive risk assessment, and increased awareness among eye care professionals. The Academy advocates for the incorporation of modern corneal imaging into routine clinical practice, particularly for individuals at increased risk, to facilitate timely intervention before irreversible structural damage and vision loss occur.
04
Pediatric Keratoconus
Recognize pediatric keratoconus as a distinct clinical priority because of its often aggressive nature and rapid progression. IKA supports routine screening of children and adolescents at increased risk through advanced corneal imaging, including Scheimpflug tomography and optical coherence tomography (OCT), with the goal of identifying disease at its earliest manifestation. The Academy remains committed to expanding research, education, and clinical awareness regarding pediatric keratoconus while promoting timely intervention to preserve lifelong visual function.
05
Interventional Keratoconus
Advance the modern paradigm of disease modification through timely, evidence-based intervention. IKA supports the appropriate utilization of corneal collagen cross-linking and other therapeutic innovations designed to stabilize disease before irreversible structural damage occurs. The Academy promotes clinical algorithms that emphasize preservation of corneal biomechanics and prevention of vision loss rather than rehabilitation after disease progression.
06
Innovation and Future Technologies
Support the research, development, scientific validation, and responsible clinical integration of transformative technologies that improve patient care. These include artificial intelligence (AI), advanced corneal imaging, optical coherence tomography (OCT), corneal biomechanics, genomics, molecular diagnostics, digital health, telemedicine, regenerative medicine, and next-generation corneal cross-linking technologies.
The Academy recognizes that artificial intelligence has the potential to fundamentally transform the diagnosis and management of keratoconus through earlier disease detection, automated image interpretation, prediction of disease progression, individualized risk assessment, personalized treatment planning, and enhanced clinical decision support. IKA is committed to promoting the responsible, ethical, and evidence-based implementation of AI-driven technologies while maintaining the highest standards of scientific rigor, transparency, patient safety, and equity in healthcare delivery.
As emerging diagnostic platforms, computational tools, and novel therapies continue to evolve, IKA will remain at the forefront of innovation by fostering multidisciplinary research, supporting collaborative clinical investigations, and accelerating the translation of scientific discovery into clinical practice.
07
Global Collaboration and Advocacy
Promote collaboration among clinicians, researchers, educators, academic institutions, industry partners, regulatory agencies, governmental organizations, and patient advocacy groups to establish evidence-based standards of care, improve access to innovative therapies, increase public awareness, and reduce the global burden of vision loss resulting from keratoconus and other corneal ectatic disorders.
08
Patient-Centered Care and Quality of Life
Promote a patient-centered approach that recognizes the lifelong impact of keratoconus on visual function, education, employment, mental health, and overall quality of life. The Academy supports clinical strategies that preserve vision, enhance functional outcomes, improve access to care, and empower patients through education, shared decision-making, and evidence-based treatment throughout every stage of disease.